Novartis AG ADR (NYSE:NVS) currently has a daily average trading volume of 1.99M but it saw 5885645 shares traded in last market. With a market cap of 223.60B USD, the company’s current market price of $113.21 came rising about 1.48 while comparing to the previous closing price of $111.56. In past 52 weeks, the stock remained buoying in the range of price level as high as $120.92 and as low as $92.35. In the recent trading on the day, stock has struck highest price mark of $112.09 while lowest mark touched by it was $113.38.
Taking a look at 20-day trading activity of Novartis AG ADR (NVS) gives us an average price of $110.97, while its current price level is -6.38% below from 52-week high level whereas it is 22.59% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $106.32 while that of 200 days or SMA-200 reads an average of $108.51. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.23% during that period while stretching the period over a month that increases to 1.37%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 60.70 which implies that the stock is in neutral territory.
Over the week, NVS’s stock price is moving 3.76% up while it is 5.89% when we observe its performance for the past one month. Year-to-date it is 16.34% up and over the past year, the stock is showing an upside performance of 18.03%.
The company is expected to be releasing its next quarterly report on 2025-Jan-30, for which analysts forecasted an EPS of 2.06 while estimate for next year EPS is 8.38. In next quarter, company is expected to be making quarterly sales of $13.66B as analysts are expecting the sales for current fiscal year at $53.08B and seeing the company making $53.89B in sales next year. Moreover, analysts are in estimates of $12.92B for current-quarter revenue.
Currently, Novartis AG ADR’s total number of outstanding shares is 1.98B with 0.00% of that held by the insiders while 6.78% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 17.83% and return on equity (ROE) at 26.33%. It has a price to earnings ratio (P/E ratio) of 19.28 while having a 13.04 of forward P/E ratio. Stock’s beta reads 0.56. Stock has a price to book (P/B) ratio of 5.08 while price to sale or P/S ratio amounts to 4.44. Its return on asset (ROA) is 11.34% on average.
